Literature DB >> 2440830

Prostate-specific antigen. Superior serum marker for prostatic carcinoma.

J A Heaney, M A Allen, T Keane, M J Duffy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2440830     DOI： 10.1007/bf02953231

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  22 in total

1.  Methods for the elimination of errors in serum acid phosphatase determinations.

Authors:  M B OZAR; C A ISAAC; W L VALK
Journal:  J Urol       Date:  1955-07       Impact factor: 7.450

2.  AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

Authors:  A B Gutman; E B Gutman
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

3.  Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.

Authors:  J H Strømme; F Haffner; N B Johannessen; T Talseth; P Frederichsen; L Theodorsen
Journal:  Scand J Clin Lab Invest       Date:  1986-09       Impact factor: 1.713

4.  A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

Authors:  H Lilja
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

5.  Evaluation of a monoclonal antibody-based immunoradiometric assay for prostatic acid phosphatase.

Authors:  S N Davies; N Gochman
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

6.  The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer.

Authors:  R A Watson; D B Tang
Journal:  N Engl J Med       Date:  1980-08-28       Impact factor: 91.245

7.  A prostate antigen in sera of prostatic cancer patients.

Authors:  L D Papsidero; M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

8.  A solid-phase radioimmunoassay for human prostatic acid phosphatase.

Authors:  A G Foti; H Herschman; J F Cooper
Journal:  Cancer Res       Date:  1975-09       Impact factor: 12.701

9.  Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.

Authors:  C S Killian; L J Emrich; F P Vargas; N Yang; M C Wang; R L Priore; G P Murphy; T M Chu
Journal:  J Natl Cancer Inst       Date:  1986-02       Impact factor: 13.506

10.  Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.

Authors:  T M Chu; M C Wang; W W Scott; R P Gibbons; D E Johnson; J D Schmidt; S A Loening; G R Prout; G P Murphy
Journal:  Invest Urol       Date:  1978-01
View more
  1 in total

1.  Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.

Authors:  W J Shih; J Collins; B Mitchell; B Wierzbinski
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.